+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Dyslipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 268 Pages
  • Global
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 181 Pages
  • Global
From
From
Antibiotic Resistance Market Report 2025 - Product Thumbnail Image

Antibiotic Resistance Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Topoisomerase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Topoisomerase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
From
From
Pediatric Vaccine Market Report 2025 - Product Thumbnail Image

Pediatric Vaccine Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
Loading Indicator